• Transmission and Genetics of Carbapenemase Genes in CREC, Ch

  2026-06-03

  This study delivers the first comprehensive molecular and epidemiological mapping of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. It reveals high plasmid-mediated transmission, predominance of blaNDM-1, and notable multidrug resistance, with practical implications for infection control and antimicrobial resistance research.

• Chloroquine Diphosphate: Transforming Autophagy for Oncology

  2026-06-02

  This article explores how Chloroquine Diphosphate (APExBIO, SKU A8628) is redefining the translational research landscape by bridging advanced autophagy modulation, ferroptosis, and therapeutic resistance in cancer. We integrate mechanistic insights, recent evidence—including the latest breakthroughs in overcoming cetuximab resistance—and strategic guidance for experimental design, setting a new standard for scientific rigor in oncology workflows.

• Tomivosertib Suppresses Human DRG Neuron Hyperactivity in Ra

  2026-06-02

  This study demonstrates that tomivosertib, a selective MNK inhibitor, rapidly and reversibly suppresses spontaneous activity in human dorsal root ganglion neurons from radiculopathy patients. The findings provide direct mechanistic insight into MNK signaling's role in neuropathic pain and establish a foundation for clinical exploration of MNK inhibition as a targeted pain intervention.

• Dacarbazine: Applied Workflows for Antineoplastic Chemothera

  2026-06-01

  Dacarbazine is a cornerstone antineoplastic chemotherapy drug, pivotal for modeling DNA damage in cancer cells and optimizing cytotoxicity assays. This article delivers protocol enhancements, troubleshooting strategies, and evidence-driven insights to maximize experimental success with APExBIO's trusted Dacarbazine.

• NF 340: A Precision P2Y11 Antagonist for Advanced Cell Signa

  2026-06-01

  NF 340 offers unmatched selectivity for the P2Y11 receptor, empowering researchers to dissect GPCR signaling in cancer and immunology. Its performance in modulating inflammation and invasiveness pathways, validated by translational studies, makes it a cornerstone for innovative assay development.

• Somatic Mutations Enable Broad SARS-CoV-2 Neutralization by

  2026-05-31

  Wu et al. reveal that specific somatic mutations in the XG005 antibody confer exceptional breadth and potency against diverse SARS-CoV-2 variants, including Omicron. Their structure-guided analysis highlights how natural antibody evolution can overcome viral immune escape, with implications for designing next-generation therapeutics.

• iPSC-Derived Multilineage Organoids Advance HEV Research Pla

  2026-05-30

  This study establishes that iPSC-derived liver, intestinal, and brain organoids can support complete pangenotype hepatitis E virus (HEV) propagation, revealing new insights into viral tropism and host-pathogen interactions. These findings offer robust, physiologically relevant models for HEV research and preclinical antiviral drug evaluation.

• Sisomicin Aminoglycoside Antibiotic: Protocols and Research

  2026-05-29

  Sisomicin empowers infection researchers with reproducible, high-precision inhibition of both Gram-negative and Gram-positive pathogens. This guide translates landmark study protocols and troubleshooting strategies into actionable workflows, leveraging APExBIO's research-grade Sisomicin for robust bacterial protein synthesis inhibition.

• Recombinant Human Oncostatin M: Protocols, Applications & Tr

  2026-05-29

  Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized) from APExBIO delivers robust, reproducible cytokine stimulation for advanced cell signaling and proliferation studies. This guide translates recent neuroimmunology breakthroughs into actionable protocols, optimizing OSM use across fibroblast, smooth muscle, and neuroglial research.

• Sulfo-Cy3 Azide: Advanced Bioconjugation Reagent for Click C

  2026-05-28

  Sulfo-Cy3 azide empowers high-fidelity Click Chemistry fluorescent labeling in complex biological systems, excelling where aqueous compatibility and photostability are critical. Featuring minimized quenching and robust water solubility, it unlocks new levels of precision in neurodevelopmental and protein labeling workflows.

• Captopril in Translational Research: Mechanisms, Models, and

  2026-05-28

  This thought-leadership article explores the mechanistic and strategic dimensions of Captopril, an ACE inhibitor, in translational research. It bridges cardiovascular and oncology domains, integrates bradykinin pathway insights, and provides actionable guidance on experimental design, protocol parameters, and emerging research frontiers, all underpinned by robust evidence and competitive differentiation.

• (R,S)-Anatabine in Alzheimer's Models: Protocols and Solutio

  2026-05-27

  (R,S)-Anatabine stands out for its selective inhibition of amyloidogenic processing and inflammation in Alzheimer's disease models, offering a precision tool for both in vitro and in vivo workflows. This guide distills actionable setup, protocol optimization, and troubleshooting tips to help researchers unlock robust, reproducible results with APExBIO’s (R,S)-Anatabine.

• 5-Ethynyl-2'-deoxyuridine (5-EdU): Precision Neurogenesis As

  2026-05-27

  Discover how 5-Ethynyl-2'-deoxyuridine (5-EdU) transforms cell proliferation assays in neurodevelopmental research. This article explores advanced mechanistic insights, practical protocol guidance, and unique applications in neurogenesis and behavioral modeling.

• Prochlorperazine (SKU A8508): Reliable Assays for Modern Lab

  2026-05-26

  This article provides scenario-driven, evidence-based guidance for biomedical researchers and lab technicians employing Prochlorperazine (SKU A8508) in cell viability, proliferation, and cytotoxicity assays. Drawing on peer-reviewed data and real-world lab pain points, it demonstrates how APExBIO’s Prochlorperazine ensures reproducibility, sensitivity, and robust experimental outcomes in cancer and antiviral research contexts.

• Atorvastatin in Cholesterol and Ferroptosis Research Workflo

  2026-05-26

  Atorvastatin is redefining its role beyond traditional cholesterol metabolism research, now serving as a robust tool for ferroptosis-driven oncology and advanced cardiovascular models. This article delivers actionable protocol enhancements, troubleshooting strategies, and a synthesis of the latest breakthroughs, including its validated use in hepatocellular carcinoma assays.

422 records 14/29 page Previous Next First page 上5页 1112131415 下5页 Last page